Seelos therapeutics to participate in two investor conferences in august

New york, july 14, 2021 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced it will participate in two investor conferences: the btig virtual biotechnology conference on august 9 th and 10th and the canaccord growth conference on august 11 th and 12th. raj mehra, ph.d.
SEEL Ratings Summary
SEEL Quant Ranking